Protein expression using ubiquitin fusion and cleavage

Current Opinion in Biotechnology

Volumn 7, Issue 5, 1996, Pages 541-546

  Baker, Rohan T ^a  

^a Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; POLYPEPTIDE; UBIQUITIN;

AMINO TERMINAL SEQUENCE; BACTERIUM; EUKARYOTE; EXPRESSION VECTOR; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SHORT SURVEY;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 0030272645     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(96)80059-0     Document Type: Article

References (42)

1. LaVallie ER, McCoy JM. Gene fusion expression systems in Escherichia coli. of special interest Curr Opin Biotechnol. 6:1995;501-506 Reviews some current gene fusion expression systems in use in E. coli with the exception of the ubiquitin fusion system.
2. Schlesinger MJ, Bond U. Ubiquitin genes. Oxf Surv Euk Genes. 4:1987;77-91.
3. Finley D, Bartel B, Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature. 338:1989;394-401.
4. Tobias JW, Varshavsky A. Cloning and functional analysis of the ubiquitin-specific protease gene Ubp1 of Saccharomyces cerevisiae. J Biol Chem. 266:1991;12021-12028.
5. Baker RT, Tobias JT, Varshavsky A. Ubiquitin-specific proteases of Saccharomyces cerevisiae. J Biol Chem. 267:1992;23364-23375.
6. Papa F, Hochstrasser M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature. 366:1993;313-319.
7. Ecker DJ, Stadel JM, Butt TR, Marsh JA, Monia BP, Powers DA, Gorman JA, Clark PE, Warren F, Shatzman A, Crooke ST. Increasing gene expression in yeast by fusion to ubiquitin. J Biol Chem. 264:1989;7715-7719.
8. Miller HI, Henzel WJ, Ridgway JB, Kuang W-J, Chisolm V, Liu C-C. Cloning and expression of a yeast ubiquitin-protein cleaving activity in Escherichia coli. Bio-Technology. 7:1989;698-704.
9. Johnson ES, Bartel B, Seufert W, Varshavsky A. Ubiquitin as a degradation signal. EMBO J. 11:1992;497-505.
10. Johnson ES, Ma PCM, Ota I, Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. of special interest J Biol Chem. 270:1995;17442-17456 Describes a proteolytic pathway in yeast responsible for degrading ubiquitin fusion proteins where the ubiquitin cannot be cleaved. Emphasizes the importance of not preventing ubiquitin cleavage in eukaryotic hosts.
11. Sabin EA, Lee-Ng CT, Shuster JR, Barr PJ. High-level expression and in vivo processing of chimeric ubiquitin fusion proteins in Saccharomyces cerevisiae. Bio-Technology. 7:1989;705-709.
12. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem. 267:1992;12692-12699.
13. Baker RT, Smith SA, Marano R, McKee J, Board PG. Protein expression using cotranslational fusion and cleavage of ubiquitin. Mutagenesis of the glutathione-binding site of human pi class glutathione S-transferase. J Biol Chem. 269:1994;25381-25386.
14. Gali RR, Board PG. Sequencing and expression of a cDNA for human glutathione synthetase. of special interest Biochem J. 310:1995;353-358 Describes a cotranslational ubiquitin fusion/cleavage system in E. coli using Ubp2p to cleave ubiquitin.
15. Tan KL, Board PG. Purification and characterization of a recombinant human theta-class glutathione transferase (GSTT2-2). of special interest Biochem J. 315:1996;727-732 Describes a cotranslational ubiquitin fusion/cleavage system in E. coli using Ubp1p to cleave ubiquitin.
16. Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast. Blood. 9:1995;2455-2460.
17. Koken MH, Odijk HH, Van Duin M, Fornerod M, Hoeijmakers JH. Augmentation of protein production by a combination of the T7 RNA polymerase system and ubiquitin fusion: overproduction of the human DNA repair protein, ERCC1, as a ubiquitin fusion protein in Escherichia coli. Biochem Biophys Res Commun. 195:1993;643-653.
18. Han K, Hong J, Lim HC, Kim CH, Park Y, Cho JM. Tyrosinase production in recombinant E. coli containing trp promoter and ubiquitin sequence. Ann NY Acad Sci. 721:1994;30-42.
19. Welch AR, Holman CM, Browner MF, Gehring MR, Kan CC, Van-Wart HE. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate. of special interest Arch Biochem Biophys. 324:1995;59-64 Describes a ubiquitin fusion system where Ubp-mediated removal of ubiquitin is not required because the fused protein is a zymogen. Cleavage is activated after purification of the intact fusion protein.
20. Mak P, McDonnell DP, Weigel NL, Schrader WT, O'Malley BW. Expression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae). J Biol Chem. 264:1989;21613-21618.
21. Lyttle CR, Damian-Matsumura P, Juul H, Butt TR. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists. J Steroid Biochem Mol Biol. 42:1992;677-685.
22. Rian E, Jemtland R, Olstad OK, Gordeladze JO, Gautvik KM. Synthesis of human parathyroid-hormone-related protein(1-141) in Saccharomyces cerevisiae. A correct amino-terminal processing vital for the hormone's biological activity is obtained by an ubiquitin fusion protein approach. Eur J Biochem. 213:1993;641-648.
23. Poletti A, Weigel NL, McDonnell DP, Schrader WT, O'Malley BW, Conneely OM. A novel, highly regulated, rapidly inducible system for the expression of chicken progesterone receptor, cPRA, in Saccharomyces cerevisiae. Gene. 114:1992;51-58.
24. Moguilevsky N, Guillaume JP, Varsalona F, Bulinckx M, Bollen A. Correct in vivo processing of a chimeric ubiquitin - proapolipoprotein A-I fusion protein in baculovirus-infected insect cells. J Biotechnol. 32:1994;39-43.
25. Butt TR, Jonnalagadda S, Monia BP, Sternberg EJ, Marsh JA, Stadel JM, Ecker DJ, Crooke ST. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci USA. 86:1989;2540-2544.
26. Gehring MR, Condon B, Margosiak SA, Kan CC. Characterization of the Phe-81 and Val-82 human fibroblast collagenase catalytic domain purified from Escherichia coli. J Biol Chem. 270:1995;22507-22513.
27. Pilon AL, Yost P, Chase TE, Lohnas GL, Bentley WE. High-level expression and efficient recovery of ubiquitin fusion proteins from Escherichia coli. of outstanding interest Biotechnol Prog. 12:1996;331-337 Describes the scale-up of the ubiquitin fusion technique to the 10 litre fermenter, and demonstrates the high yields that can be obtained from this system. Also reports a further yield enhancement following a heat shock during fermentation.
28. McDonnel DP, Pike JW, Drutz DJ, Butt TR, O'Malley BW. Reconstitution of the vitamin-D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae. Mol Cell Biol. 9:1989;3517-3523.
29. Lu C, Yang Y-F, Ohashi H, Walfish PG. In vivo expression of rat liver c-erbA beta thyroid hormone receptor in yeast (Saccharomyces cerevisiae). Biochem Biophys Res Commun. 171:1990;138-142.
30. Barr PJ, Inselburg J, Green KM, Kansopon J, Hahm BK, Gibson HL, Lee-Ng CT, Bzik DJ, Li W, Bathurst IC. Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents. Mol Biochem Parasitol. 45:1991;159-170.
31. McDonnell DP, Nawaz Z, Densmore C, Weigel NL, Pham TA, Clark JH, O'Malley BW. High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J Steroid Biochem Mol Biol. 39:1991;291-297.
32. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science. 234:1986;179-186.
33. Varshavsky A. The N-end rule. Cell. 69:1992;725-735.
34. Yoo Y, Watts S, Rechsteiner M. Ubiquitin - RAS peptide extensions as substrates for farnesyl-protein transferase and carboxymethyltransferase. Biochem J. 285:1992;55-60.
35. Moguilevsky N, Varsalona F, Guillaume JP, Gilles P, Bollen A, Roobol K. Production of authentic human proapolipoprotein A-I in Escherichia coli: strategies for the removal of the amino-terminal methionine. J Biotechnol. 27:1993;159-172.
36. Tobias JW, Shrader TE, Rocap G, Varshavsky A. The N-end rule in bacteria. Science. 254:1991;1374-1377.
37. Gonda D, Bachmair A, Wünning I, Tobias JW, Lane WS, Varshavsky A. Universality and structure of the N-end rule. J Biol Chem. 264:1989;16700-16712.
38. Balzi E, Choder M, Chen W, Varshavsky A, Goffeau A. Cloning and functional analysis of the arginyl-tRNA - protein transferase gene ATE1 of Saccharomyces cerevisiae. J Biol Chem. 265:1990;7464-7471.
39. Baker RT, Varshavsky A. Yeast N-terminal armidase: a new enzyme and component of the N-end rule pathway. J Biol Chem. 270:1995;12065-12074.
40. Lemm JA, Rumenapf T, Strauss EG, Strauss JH, Rice CM. Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis. EMBO J. 13:1994;2925-2934.
41. Dohmen RJ, Wu P, Varshavsky A. Heat-inducible degron: a method for constructing temperature-sensitive mutants. Science. 263:1994;1273-1276.
42. Johnsson N, Varshavsky A. Split ubiquitin as a sensor of protein interactions in vivo. Proc Natl Acad Sci USA. 91:1994;10340-10344.